This AI work is normally not classified as “GenAI” which is what I was responding to, and the parent was specifically talking about LLMs. Usually GenAI specifically refers to LLMs as well as image/video creation.
The big data centers aren’t for the most part being built for pharma research.
This AI work is normally not classified as “GenAI” which is what I was responding to, and the parent was specifically talking about LLMs. Usually GenAI specifically refers to LLMs as well as image/video creation.
The big data centers aren’t for the most part being built for pharma research.
Most part, no. Significant chunk, certainly. Here are some of the larger ongoing contracts:
Eli Lilly & Insilico Medicine ($2.75 Billion)
Merck KGaA & Valo Health (Up to $3.0 Billion)
Roche & Manifold Bio (Up to $2.0 Billion)
AbbVie & Gilgamesh Pharmaceuticals (Up to $2.0 Billion)
Novartis & Relation Therapeutics (Up to $1.7 Billion)
Isomorphic Labs (Alphabet) with Eli Lilly & Novartis ($2.9 Billion Combined)
Eli Lilly & NVIDIA ($1 Billion)